← Open Payments lookup

LYNDSEY O'ROURKE: Open Payments

NPI 1801367743 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,765 in 212 payments from 21 companies in 2025. Trend: 2023 $3,767 · 2024 $5,096 · 2025 $6,765

Food & beverage: $5,520Consulting: $1,245
CompanyPaymentsAmount
Janssen Biotech, Inc.18$1,888
ABBVIE INC.56$1,387
Gilead Sciences, Inc.20$487
Lilly USA, LLC12$429
Takeda Pharmaceuticals U.S.A., Inc.14$407
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$377
Madrigal Pharmaceuticals10$339
Phathom Pharmaceuticals, Inc.8$223
QOL Medical, LLC17$220
Regeneron Healthcare Solutions, Inc.8$205

Products named: TREMFYA, SKYRIZI, XIFAXAN, REZDIFFRA, ENTYVIO, OMVOH, DUPIXENT, RINVOQ.

Industry payments across CO — which companies pay providers there.